MONOCYTIC MYELOID-DERIVED SUPPRESSOR CELL EXPANSION AFTER CARDIAC SURGERY WITH CARDIOPULMONARY BYPASS INDUCES LYMPHOCYTE DYSFUNCTION

ABSTRACT Cardiac surgery with cardiopulmonary bypass (CPB) is associated with an immune paresis that predisposes to the development of postoperative infections and sepsis. Among factors responsible for CPB-induced immunosuppression, circulating myeloid-derived suppressor cells (MDSCs) have been found to induce early lymphocyte apoptosis and lymphocyte proliferation inhibition. However, the mechanisms involved are not fully understood. In this study, we found that the main lymphocyte subsets decreased significantly 24 h after cardiac surgery with CBP. As expected, cardiac surgery with CPB induced a monocytic MDSC expansion associated with an increased T-cell apoptosis and decreased proliferation capacity. Noteworthy, granulocytic MDSCs remain stable. Myeloid-derived suppressor cell depletion restored the ability of T-cell to proliferate ex vivo. After CPB, indoleamine 2,3-dioxygenase activity and IL-10 plasma level were increased such as programmed death-ligand 1 monocytic expression, whereas plasma level of arginine significantly decreased. Neither the inhibition of indoleamine 2,3-dioxygenase activity nor the use of anti–programmed death-ligand 1 or anti–IL-10 blocking antibody restored the ability of T-cell to proliferate ex vivo. Only arginine supplementation restored partially the ability of T-cell to proliferate.

[1]  K. Tarte,et al.  Neutrophil function and bactericidal activity against Staphylococcus aureus after cardiac surgery with cardiopulmonary bypass , 2021, Journal of leukocyte biology.

[2]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity , 2021, Nature Reviews Immunology.

[3]  K. Tarte,et al.  Venoarterial extracorporeal membrane oxygenation induces early immune alterations , 2021, Critical Care.

[4]  K. Tarte,et al.  SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage , 2021, Journal of clinical immunology.

[5]  C. Maldonado-Bernal,et al.  Effects of cardiopulmonary bypass on the development of lymphopenia and sepsis after cardiac surgery in children with congenital cardiopathy , 2019, Experimental and therapeutic medicine.

[6]  Marie-Pierre L. Gauthier,et al.  Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis , 2019, Critical Care.

[7]  E. Schwedhelm,et al.  Myeloid-Derived Suppressor Cells Mediate Immunosuppression After Cardiopulmonary Bypass. , 2019, Critical care medicine.

[8]  P. Vignon,et al.  Immature Granulocytes: A Risk Factor of Infection after Cardiac Surgery , 2018, Cytometry. Part B, Clinical cytometry.

[9]  J. Morel,et al.  Postoperative lymphopenia: An independent risk factor for postoperative pneumonia after lung cancer surgery, results of a case-control study , 2018, PloS one.

[10]  F. Venet,et al.  Advances in the understanding and treatment of sepsis-induced immunosuppression , 2018, Nature Reviews Nephrology.

[11]  D. Gabrilovich,et al.  Myeloid-derived suppressor cells coming of age , 2018, Nature Immunology.

[12]  K. Tarte,et al.  Early Expansion of Circulating Granulocytic Myeloid‐derived Suppressor Cells Predicts Development of Nosocomial Infections in Patients with Sepsis , 2017, American journal of respiratory and critical care medicine.

[13]  C. Van Waes,et al.  Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ. , 2017, Cancer research.

[14]  Peter J. Murray,et al.  Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards , 2016, Nature Communications.

[15]  A. Spittler,et al.  Effect of hemoadsorption during cardiopulmonary bypass surgery – a blinded, randomized, controlled pilot study using a novel adsorbent , 2016, Critical Care.

[16]  D. Gabrilovich,et al.  The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. , 2016, Trends in immunology.

[17]  S. Yusuf,et al.  Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial , 2015, The Lancet.

[18]  M. Singer,et al.  Metabolic dysfunction in lymphocytes promotes postoperative morbidity. , 2015, Clinical science.

[19]  K. Tarte,et al.  Immune Dysfunction After Cardiac Surgery with Cardiopulmonary Bypass: Beneficial Effects of Maintaining Mechanical Ventilation , 2015, Shock.

[20]  W. Buhre,et al.  Monocyte hyporesponsiveness and Toll-like receptor expression profiles in coronary artery bypass grafting and its clinical implications for postoperative inflammatory response and pneumonia: An observational cohort study , 2015, European journal of anaesthesiology.

[21]  K. Wernecke,et al.  Dysfunction of alveolar macrophages after cardiac surgery and postoperative pneumonia? - an observational study , 2013, Critical Care.

[22]  C. Stratton,et al.  Management of immune dysfunction after adult cardiac surgery. , 2011, The Journal of thoracic and cardiovascular surgery.

[23]  E John Wherry,et al.  T cell exhaustion , 2011 .

[24]  Silvano Sozzani,et al.  Nomenclature of monocytes and dendritic cells in blood. , 2010, Blood.

[25]  Thierry Fest,et al.  Refining the white blood cell differential: The first flow cytometry routine application , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[26]  P. Rosseel,et al.  Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe , 2009, Critical care.

[27]  A. Raddatz,et al.  Effects of Haemofiltration and Mannitol Treatment on Cardiopulmonary‐Bypass Induced Immunosuppression , 2009, Scandinavian journal of immunology.

[28]  Yufang Shi,et al.  Apoptotic Cells Induce Immunosuppression through Dendritic Cells: Critical Roles of IFN-γ and Nitric Oxide1 , 2008, The Journal of Immunology.

[29]  Yufang Shi,et al.  Apoptotic Cells Induce Immunosuppression through Dendritic Cells: Critical Roles of Interferon‐gamma and Nitric Oxide , 2008 .

[30]  S. Foster,et al.  ALTERATIONS IN INFLAMMATORY CAPACITY AND TLR EXPRESSION ON MONOCYTES AND NEUTROPHILS AFTER CARDIOPULMONARY BYPASS , 2007, Shock.

[31]  A. Markewitz,et al.  Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood? , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[32]  E. Pamer,et al.  Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2 , 2006, Nature Immunology.

[33]  J. Lundahl,et al.  Peripheral blood monocyte activation during coronary artery bypass grafting with or without cardiopulmonary bypass , 2005, Scandinavian cardiovascular journal : SCJ.

[34]  S. Heisterkamp,et al.  Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial , 2001, The Lancet.

[35]  M. Kollef,et al.  The impact of nosocomial infections on patient outcomes following cardiac surgery. , 1997, Chest.

[36]  H. Zola,et al.  Isolation of Whole Mononuclear Cells from Peripheral Blood and Cord Blood , 1996, Current protocols in immunology.